Patent details
EP3730134 Title: MEDICINAL COMPOSITION FOR PREVENTING OR TREATING SECONDARY HYPERPARATHYROIDISM UNDER MAINTENANCE DIALYSIS
Basic Information
- Publication number:
- EP3730134
- PCT Application Number:
- JP2018046679
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188930747
- PCT Publication Number:
- WO2019124411
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MEDICINAL COMPOSITION FOR PREVENTING OR TREATING SECONDARY HYPERPARATHYROIDISM UNDER MAINTENANCE DIALYSIS
- French Title of Invention:
- COMPOSITION MÉDICINALE POUR LA PRÉVENTION OU LE TRAITEMENT DE L'HYPERPARATHYROÏDIE SECONDAIRE EN DIALYSE D'ENTRETIEN
- German Title of Invention:
- MEDIZINISCHE ZUSAMMENSETZUNG ZUR VORBEUGUNG ODER BEHANDLUNG VON SEKUNDÄREM HYPERPARATHYROIDISMUS UNTER DER ERHALTUNGSDIALYSE
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 10/06/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 18/06/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 14/05/2025
- Unitary Effect Registration Date:
- 18/06/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/12/2018
- Grant date:
- 14/05/2025
- EP Publication Date:
- 28/10/2020
- PCT Publication Date:
- 27/06/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/05/2025
- EP B1 Publication Date:
- 14/05/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/12/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/05/2025
- Name:
- EA Pharma Co., Ltd.
- Address:
- 2-1-1, Irifune Chuo-ku, Tokyo 104-0042, Japan (JP)
Inventor
1
- Name:
- KUYAMA Kazuo
- Address:
- Japan (JP)
2
- Name:
- KATAOKA Daisuke
- Address:
- Japan (JP)
3
- Name:
- WAGATSUMA Hirotaka
- Address:
- Japan (JP)
4
- Name:
- ASANO Kenji
- Address:
- Japan (JP)
5
- Name:
- TSURUTA Atsushi
- Address:
- Japan (JP)
6
- Name:
- TAKANOHASHI Toshiyuki
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2017244149
- Priority Date:
- 20/12/2017
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- A61K 31/198; A61P 5/18; C07C 275/42; A61K 45/06; A61K 33/06; A61K 31/59;
Publication
European Patent Bulletin
1
- Issue number:
- 202520
- Publication date:
- 14/05/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202529
- Publication date:
- 16/07/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202530
- Publication date:
- 23/07/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|